Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Market Cap

Protagonist Therapeutics has a market cap or net worth of $1.51 billion as of May 7, 2024. Its market cap has increased by 30.51% in one year.

• Market Cap: 1.51B
• Enterprise Value: 1.17B
• 1-Year Change: 30.51%
• Ranking: #2147
• Category: Small-Cap
• Stock Price: $25.79

Market Cap Chart

Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $1.51B, an increase of 781.87%. That is a compound annual growth rate of 32.48%.

Market Cap History

Date	Market Cap	% Change
May 6, 2024	1.52B	-0.12%
May 3, 2024	1.52B	2.16%
May 2, 2024	1.49B	-0.08%
May 1, 2024	1.49B	1.79%
Apr 30, 2024	1.46B	-1.76%
Apr 29, 2024	1.49B	1.63%
Apr 26, 2024	1.47B	1.98%
Apr 25, 2024	1.44B	-4.05%
Apr 24, 2024	1.50B	-4.28%
Apr 23, 2024	1.56B	0.90%
Apr 22, 2024	1.55B	3.91%
Apr 19, 2024	1.49B	1.54%
Apr 18, 2024	1.47B	-1.37%
Apr 17, 2024	1.49B	-2.07%
Apr 16, 2024	1.52B	-1.76%
Apr 15, 2024	1.55B	-1.71%
Apr 12, 2024	1.58B	-2.24%
Apr 11, 2024	1.61B	-0.79%
Apr 10, 2024	1.62B	-4.29%
Apr 9, 2024	1.70B	3.71%
Apr 8, 2024	1.64B	0.32%
Apr 5, 2024	1.63B	1.27%
Apr 4, 2024	1.61B	-1.50%
Apr 3, 2024	1.64B	0.29%
Apr 2, 2024	1.63B	-1.03%

View and export this data all the way back to 2016. Sign Up Today.

Related Stocks

Company	Market Cap
Veracyte	1.57B
Soleno Therapeutics	1.53B
Akero Therapeutics	1.52B
Dynavax Technologies	1.52B
Morphic Holding	1.52B
Warby Parker	1.51B
Xencor	1.50B
Neumora Therapeutics	1.49B